Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Appropriate protamine dosage for post cardiopulmonary bypass patients with borderline activated clotting time
TCTR20190308003Phase 3Recruiting
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of protamine in coagulation defects, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Mar 2019; status: recruiting.
02
Drugs
protamine
03
Conditions
coagulation defects
Beyond the preview
Go deeper on TCTR20190308003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190308003.